For CFO Krognes, Neurosci Startup Denali Taps Genentech Again

Denali Therapeutics of South San Francisco, CA, said Tuesday it has brought on Steve Krognes as chief financial officer. Krognes comes from Genentech, where he was CFO and a member of the firm’s executive committee since 2009. Denali launched in May with a huge cash commitment from its backers and three Genentech alumni: chairman Marc Tessier-Lavigne, CEO Ryan Watts, and COO Alex Schuth. Denali CMO Carole Ho is also a Genentech alum.

Author: Alex Lash

I've spent nearly all my working life as a journalist. I covered the rise and fall of the dot-com era in the second half of the 1990s, then switched to life sciences in the new millennium. I've written about the strategy, financing and scientific breakthroughs of biotech for The Deal, Elsevier's Start-Up, In Vivo and The Pink Sheet, and Xconomy. View all posts by Alex Lash